Calliditas Therapeutics AB
STO:CALTX

Watchlist Manager
Calliditas Therapeutics AB Logo
Calliditas Therapeutics AB
STO:CALTX
Watchlist
Price: 208 SEK 0.87% Market Closed
Market Cap: 11.2B SEK
Have any thoughts about
Calliditas Therapeutics AB?
Write Note

Relative Value

The Relative Value of one CALTX stock under the Base Case scenario is 436.68 SEK. Compared to the current market price of 208 SEK, Calliditas Therapeutics AB is Undervalued by 52%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CALTX Relative Value
Base Case
436.68 SEK
Undervaluation 52%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
63
vs Industry
17
Median 3Y
7
Median 5Y
15.6
Industry
2.6
Forward
5.6
vs History
vs Industry
Median 3Y
-11.6
Median 5Y
-13.2
Industry
22.3
Forward
89.3
vs History
vs Industry
Median 3Y
-14.7
Median 5Y
-17
Industry
17.5
vs History
vs Industry
Median 3Y
-17.4
Median 5Y
-19.3
Industry
24.8
vs History
0
vs Industry
0
Median 3Y
8.5
Median 5Y
5.8
Industry
2.1
vs History
60
vs Industry
15
Median 3Y
6.8
Median 5Y
11.8
Industry
2.7
Forward
5.7
vs History
15
vs Industry
22
Median 3Y
5.9
Median 5Y
4.1
Industry
5.3
vs History
vs Industry
Median 3Y
-12.2
Median 5Y
-15
Industry
13.4
Forward
58.4
vs History
vs Industry
Median 3Y
-12.1
Median 5Y
-15
Industry
16.8
Forward
63.8
vs History
vs Industry
Median 3Y
-14.3
Median 5Y
-15.8
Industry
15.9
vs History
vs Industry
Median 3Y
-14.2
Median 5Y
-15.8
Industry
18.5
vs History
22
vs Industry
8
Median 3Y
8.1
Median 5Y
9.6
Industry
1.9

Multiples Across Competitors

CALTX Competitors Multiples
Calliditas Therapeutics AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Calliditas Therapeutics AB
STO:CALTX
11.2B SEK 7 -23.4 -32.4 -32.4
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
788.6B USD 20.3 107.4 53.8 60.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.4T DKK 13.1 37.5 25 28.7
US
Johnson & Johnson
NYSE:JNJ
384.8B USD 4.4 26.2 12.6 16.5
US
Merck & Co Inc
NYSE:MRK
259.4B USD 4.2 18.9 12.8 15.8
CH
Roche Holding AG
SIX:ROG
213.6B CHF 3.6 18.6 10.4 12.4
UK
AstraZeneca PLC
LSE:AZN
171.2B GBP 4.5 34.3 170.5 255.6
CH
Novartis AG
SIX:NOVN
183.5B CHF 4.3 13.1 10.4 15.4
US
Pfizer Inc
NYSE:PFE
160.4B USD 2.7 37.7 11 16.7
P/E Multiple
Earnings Growth
SE
Calliditas Therapeutics AB
STO:CALTX
Average P/E: 36.7
Negative Multiple: -23.4
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
107.4
454%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
37.5
89%
US
Johnson & Johnson
NYSE:JNJ
26.2
-22%
US
Merck & Co Inc
NYSE:MRK
18.9
7 426%
CH
Roche Holding AG
SIX:ROG
18.6
30%
UK
AstraZeneca PLC
LSE:AZN
34.3
175%
CH
Novartis AG
SIX:NOVN
13.1
19%
US
Pfizer Inc
NYSE:PFE
37.7
712%

See Also

Discover More
Back to Top